These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains. Chen XZ; Xu P; Liu L; Zheng D; Lei PS Eur J Med Chem; 2011 Jan; 46(1):208-17. PubMed ID: 21130543 [TBL] [Abstract][Full Text] [Related]
3. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens. Nomura T; Yasukata T; Narukawa Y; Uotani K Bioorg Med Chem; 2005 Nov; 13(21):6054-63. PubMed ID: 15994088 [TBL] [Abstract][Full Text] [Related]
4. 4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens. Fajdetić A; Cipcić Paljetak H; Lazarevski G; Hutinec A; Alihodzić S; Derek M; Stimac V; Andreotti D; Sunjić V; Berge JM; Mutak S; Dumić M; Lociuro S; Holmes DJ; Marsić N; Eraković Haber V; Spaventi R Bioorg Med Chem; 2010 Sep; 18(17):6559-68. PubMed ID: 20634078 [TBL] [Abstract][Full Text] [Related]
5. [Advance in synthesis of ketolides, a new class of erythromycin derivatives]. Lei PS; Xu P; Liu L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):467-73. PubMed ID: 15379279 [TBL] [Abstract][Full Text] [Related]
6. A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: synthesis and structure-activity relationships. Nomura T; Iwaki T; Narukawa Y; Uotani K; Hori T; Miwa H Bioorg Med Chem; 2006 Jun; 14(11):3697-711. PubMed ID: 16460944 [TBL] [Abstract][Full Text] [Related]
7. Dissecting the ribosomal inhibition mechanism of a new ketolide carrying an alkyl-aryl group at C-13 of its lactone ring. Krokidis MG; Kostopoulou ON; Kalpaxis DL; Dinos GP Int J Antimicrob Agents; 2010 Mar; 35(3):235-9. PubMed ID: 20045632 [TBL] [Abstract][Full Text] [Related]
8. Macrolide and ketolide resistance with Streptococcus pneumoniae. Doern GV Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships and mechanism of action of macrolides derived from erythromycin as antibacterial agents. Liang JH; Han X Curr Top Med Chem; 2013; 13(24):3131-64. PubMed ID: 24200358 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides. Hu L; Lan P; Song QL; Huang ZJ; Sun PH; Zhuo C; Wang Y; Xiao S; Chen WM Eur J Med Chem; 2010 Dec; 45(12):5943-9. PubMed ID: 20970894 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624 [TBL] [Abstract][Full Text] [Related]
13. A simple method for deprotection of the N- and O-carbobenzoxy groups and N-methylation of the desosamine sugar moiety of ketolides. Application to the synthesis of ketolide analogues with various 9-iminoether moieties and their antibacterial activities. Iwaki T; Nomura T; Narukawa Y; Uotani K J Antibiot (Tokyo); 2005 Nov; 58(11):679-85. PubMed ID: 16466021 [TBL] [Abstract][Full Text] [Related]
14. A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure-activity relationships. Nomura T; Iwaki T; Yasukata T; Nishi K; Narukawa Y; Uotani K; Hori T; Miwa H Bioorg Med Chem; 2005 Dec; 13(24):6615-28. PubMed ID: 16140535 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and antibacterial activity of novel ketolides bearing an aryltetrazolyl-substituted alkyl side chain. Song QL; Guo BQ; Zhang W; Lan P; Sun PH; Chen WM J Antibiot (Tokyo); 2011 Aug; 64(8):571-81. PubMed ID: 21772308 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of novel C12 vinyl ketolides. Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588 [TBL] [Abstract][Full Text] [Related]
17. Combinatorial biosynthesis of 5-O-desosaminyl erythronolide A as a potent precursor of ketolide antibiotics. Basnet DB; Park JW; Yoon YJ J Biotechnol; 2008 May; 135(1):92-6. PubMed ID: 18430483 [TBL] [Abstract][Full Text] [Related]
18. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics. Fernandes P; Pereira D; Watkins PB; Bertrand D J Med Chem; 2020 Jun; 63(12):6462-6473. PubMed ID: 31644280 [TBL] [Abstract][Full Text] [Related]
19. The wobbly status of ketolides: where do we stand? Georgopapadakou NH Expert Opin Investig Drugs; 2014 Oct; 23(10):1313-9. PubMed ID: 25154307 [TBL] [Abstract][Full Text] [Related]
20. Nature nurtures the design of new semi-synthetic macrolide antibiotics. Fernandes P; Martens E; Pereira D J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]